Ledger.Open graph →

SEC Form D · Amendment · filed August 18, 2025

Rezo Therapeutics, Inc

Offering

$80.1M

Sold

$68.1M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

SAN FRANCISCO, CA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

Tiba Aynechi · SAN FRANCISCO, CADirector Nevan Krogan · SAN FRANCISCO, CAExec · Director Simeon George · SAN FRANCISCO, CADirector Norbert Bischofberger · SAN FRANCISCO, CADirector George Scangos · SAN FRANCISCO, CADirector Vineeta Agarwala · SAN FRANCISCO, CADirector Carolina Hernandez · Frisco, TXDirector Lauryn Hunnicutt · Frisco, TXDirector Chad Chen · GARDENA, CADirector Hani Barhoush · Abu Dhabi, C0Exec · Director Alexander Pattis · New York, NYDirector Sonia Johnson · Frisco, TXDirector Derek Hicks · SAN FRANCISCO, CAExec · Director Jennifer Chang · SAN FRANCISCO, CAExec Anthony Laxen · Bloomington, MNDirector Politan Capital Management LP · New York, NYExec · Director Godwin Capital Group, LLC · Atlanta, GADirector Mckenzie Glandorf · Scottsdale, AZDirector James Guerra · Scottsdale, AZDirector Oshiogwe Braimah · Scottsdale, AZDirector Derek Hicks · SAN FRANCISCO, CAExec · Director Jennifer Chang · SAN FRANCISCO, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗